WILLIAM CHU: Open Payments
NPI 1043227804 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,352 in 66 payments from 14 companies in 2025. Trend: 2023 $3,561 · 2024 $2,839 · 2025 $2,352
Food & beverage: $2,352
| Company | Payments | Amount |
|---|---|---|
| Verona Pharma, Inc. | 16 | $417 |
| AstraZeneca Pharmaceuticals LP | 5 | $401 |
| Amgen Inc. | 11 | $303 |
| Ardelyx, Inc. | 6 | $267 |
| Phathom Pharmaceuticals, Inc. | 2 | $173 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $156 |
| GlaxoSmithKline, LLC. | 2 | $138 |
| Dexcom, Inc. | 5 | $132 |
| ABBVIE INC. | 4 | $114 |
| Abbott Laboratories | 3 | $94 |
Products named: Ohtuvayre, IBSRELA, BREZTRI, OTEZLA, VOQUEZNA, Kerendia, AIRSUPRA, Dexcom G6 Transmitter.
Industry payments across CA — which companies pay providers there.
